ArticleSurgical neurology international2026
Quantitative spectroscopic analysis of talaporfin sodium fluorescence: Utility in fluorescence-guided surgery and detection of invasive tumor cells in glioblastoma.
Article in Surgical neurology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Talaporfin sodium (TS) has been widely used as photodynamic therapy (PDT) for glioblastoma (GB), but its sensitivity and selectivity in fluorescence-guided surgery are not fully understood. This study aimed to elucidate whether quantitative analysis of spectroscopic TS fluorescence intensity could evaluate the degrees of glioma cell infiltration in the peritumoral area. Methods: The study included 12 patients with recurrent GB who underwent surgical resection and PDT with TS. Primary tumors were classified into high-invasive (HI) and low-invasive (LI) subtypes based on magnetic resonance imaging. TS-fluorescence intensities were analyzed using fluorescence spectroscopy. A relationship between TS-fluorescence intensities that were measured in four subareas divided according to the signal intensity and degrees of tumor activity evaluated by Ki-67 staining index (SI) was investigated. Results: Five tumors were HI type and seven were LI type. Both progression-free survival after surgical reresection and PDT with TS and overall survival were significantly longer in patients with the LI-type GB compared to the HI-type. The median Ki-67 SI in the area with a signal intensity >5000 arbitrary units (a.u.) was 23.5%, 3000-5000 a.u. was 10.0%, and 1000-3000 a.u. was 2.70%. When the TS signal intensity was <1000 a.u., almost no tumor cells were detected in the peritumoral tissue. Conclusion: Tumor invasiveness was assessed by quantitative analysis of TS-fluorescence spectroscopy during GB surgery. They correlated with tumor density assessed by Ki-67 SI. Aggressive surgical resection, including regions with TS fluorescence intensity >1000 a.u., should be considered for maximum resection of GBs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.